Certara, a provider of software for in model-informed drug development and regulatory science, has announced the launch of Phoenix 8.0
Certara, a specialist in model-informed drug development has announced that it has developed a report on viral kinetic (VK) modelling to accelerate research into drug-resistant strains of influenza
Certara, a provider of software for model-informed drug development and regulatory science, today announced that it has added externalisation technology to its D360 scientific informatics platform
Certara has announced that it is partnering with Phase I Unit, Peking Union Medical College (PUMC) Hospital’s Clinical Pharmacology Research Center (PUMCH-CPRC) in Beijing to help Chinese pharmaceutical companies enhance their drug development processes
Certara, a provider of decision support technology and consulting services to optimise drug development and improve health outcomes, has announced that it has acquired d3 Medicine. d3 Medicine, which is based in Parsippany, NJ, and Melbourne, Australia, provides strategic planning and stewardship of complex drug development programs.
Certara, a provider of decision support technology and consulting services for optimising drug development and improving health outcomes, has announced the launch of Phoenix 7.0. Phoenix is an advanced, intuitive software for pharmacokinetic (PK), pharmacodynamic (PD), and toxicokinetic (TK) modelling and simulation.
Certara, the provider of decision support technology and consulting services for optimising drug development and improving health outcomes, has announced the availability of D360 Express
Certara, the global biosimulation technology-enabled drug development company, and Paidion Research, a pediatric clinical research organization (CRO), have announced a new partnership dedicated to promoting more efficient and reliable drug development for pediatric patients
Certara, a global biosimulation drug development company, has announced the merger of its consulting group, Pharsight Consulting Services (PCS), with Quantitative Solutions, a global pharmacometrics consulting company headquartered in Menlo Park, California
Certara, a global technology-enabled drug development and drug safety consultancy, has announced that it has released version 14 of its Simcyp Population-based Simulator
Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets
Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users